There’s a New Obesity King - The Wall Street Journal

1. There’s a New Obesity King  The Wall Street Journal
2. Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps  CNBC
3. An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment  CNN
4. Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results  Yahoo Finance